Is the 'holy grail' cystic fibrosis medication worth the risk?  

Elaina Mowle, 22, from Eastbourne began having problems after being started on Symkevi and Kalydeco, aged 19. She said: ''After about a week I began to feel really spaced out.'
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cystic Fibrosis | Health